Cambridge’s Qureight raises $20M to bring AI to lung and heart clinical trials

Qureight, a Cambridge-based company developing AI imaging tools for lung and heart clinical trials, has raised $20 million in funding. The investment will support the expansion of its platform that uses artificial intelligence to analyze medical images and accelerate drug development.

Qureight, a Cambridge company building AI imaging tools for lung and heart clinical trials, has closed a $20…